Company / Tangible Book Value per Share
10x Genomics, Inc. Tangible Book Value per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$6.47
FY2025
5-year range
$5.92 / $7.49
FY2021-FY2025
Trend
+9.3%
vs FY2024
Sector context
#69 of 163
Health Care
What the data says
At $6.47, 10x Genomics, Inc.'s tangible book value per share ranks #69 of 163 in the Health Care sector. Tangible Book Value per Share returned to growth in FY2025 after 5 years of decline, reaching $6.47.
Based on SEC 10-K filings.
6.47 in FY2025 with a 5-year CAGR of -3.4%.
Remained stable around $6.47 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -3.1%
- 5-Year CAGR
- -3.4%
- 10-Year CAGR
- -
Sector benchmark
#69 of 163 in Health CareTop 42% of 163This company $6.47 Sector average $18.18
▼
-64.4% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 9.3% year-over-year.
- Ranks #69 out of 163 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2019.
- Lowest tangible book value per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.47 | +9.3% |
| FY2024 | $5.92 | -7.3% |
| FY2023 | $6.39 | -10.2% |
| FY2022 | $7.12 | -5.0% |
| FY2021 | $7.49 | -2.4% |
| FY2020 | $7.68 | -73.4% |
| FY2019 | $28.87 | +275.8% |
| FY2018 | -$16.43 | -69.2% |
| FY2017 | -$9.71 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026